DBS said it will stay overweight US and European equities due to negative real rates and elevated equity risk premium (ERP).

DBS said it will stay overweight US and European equities due to negative real rates and elevated equity risk premium (ERP).
But the firm remains nervous about China property borrowers.
FSA compares two US equities products: the Lazard US Equity Concentrated Fund and the T Rowe Price US Large Cap Growth Equity Fund.
FSA compares two US equity products: the Morgan Stanley US Growth Fund and the T Rowe Price US Large Cap Growth Equity Fund.
While China’s economic rebound stalls and the US economy holds steady, Invesco favours European and emerging market equities.
This week FSA presents a quick comparison of two US equities products: the MFS Meridian US Value Fund and the Morgan Stanley US growth Fund.
FSA compares two US equity products: the Fidelity America Fund and the Loomis Sayles US Growth Equity Fund.
FSA compares two US equity products: the Franklin US Opportunities Fund and the Neuberger Berman US Multi Cap Opportunities Fund.
This week FSA presents a quick comparison of two North America equity products: the AB Select US Equity Portfolio and the JPMorgan America Equity Fund.
FSA compares two US growth equities products: the Franklin US Opportunities Fund and the Natixis Loomis Sayles US Growth Equity Fund.
Part of the Mark Allen Group.